Description
for the treatment of obese patients with a body mass index (BMI) greater than or equal to 30 kg/m2, or overweight patients (BMI =28 kg/m2) with associated risk factors.
SIDE EFFECTS
nausea, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).